Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Autoimmune Disease

Creative Biolabs provides a comprehensive range of recombinant antibodies used in various projects. We have offered a mass of services for our clients to support autoimmune disease diagnostics.

Autoimmunity involves the loss of normal immune homeostasis such that the organism produces an abnormal response to its own self-tissue. Laboratory testing is very important when it comes to evaluating an individual with a suspected autoimmune disease. The results confirm a diagnosis, estimate disease severity, aid in assessing prognosis and are useful to follow disease activity. A variety of laboratory examinations for autoimmune diseases have been established. They include complete blood count with differential, comprehensive metabolic panel, the test of inflammatory markers, autoantibodies, and the utilization of flow cytometry.